title: A phase II study of iproplatin in advanced or metastatic stomach cancer. The EORTC Early Clinical Trial Group.
authors: Ospedale San Giovanni, Bellinzona, Switzerland.
authors: C
authors: C
authors: Sessa
authors: T
authors: T
authors: Cerny
authors: S
authors: S
authors: Kaye
authors: S
authors: S
authors: Monfardini
authors: J
authors: J
authors: Rénard
authors: F
authors: F
authors: Cavalli
mesh_terms: D000230:Adenocarcinoma / Q000188:drug therapy*; D000328:Adult; D000368:Aged; D000970:Antineoplastic Agents / Q000009:adverse effects / Q000627:therapeutic use*; D004341:Drug Evaluation; D005260:Female; D006801:Humans; D008297:Male; D008875:Middle Aged; D009362:Neoplasm Metastasis; D009944:Organoplatinum Compounds / Q000009:adverse effects / Q000627:therapeutic use*; D013274:Stomach Neoplasms / Q000188:drug therapy*
chemical_list: D000970:Antineoplastic Agents; D009944:Organoplatinum Compounds; C023359:iproplatin